Letter | Published:

A non-canonical Notch complex regulates adherens junctions and vascular barrier function

Nature volume 552, pages 258262 (14 December 2017) | Download Citation


The vascular barrier that separates blood from tissues is actively regulated by the endothelium and is essential for transport, inflammation, and haemostasis1. Haemodynamic shear stress plays a critical role in maintaining endothelial barrier function2, but how this occurs remains unknown. Here we use an engineered organotypic model of perfused microvessels to show that activation of the transmembrane receptor NOTCH1 directly regulates vascular barrier function through a non-canonical, transcription-independent signalling mechanism that drives assembly of adherens junctions, and confirm these findings in mouse models. Shear stress triggers DLL4-dependent proteolytic activation of NOTCH1 to expose the transmembrane domain of NOTCH1. This domain mediates establishment of the endothelial barrier; expression of the transmembrane domain of NOTCH1 is sufficient to rescue defects in barrier function induced by knockout of NOTCH1. The transmembrane domain restores barrier function by catalysing the formation of a receptor complex in the plasma membrane consisting of vascular endothelial cadherin, the transmembrane protein tyrosine phosphatase LAR, and the RAC1 guanidine-exchange factor TRIO. This complex activates RAC1 to drive assembly of adherens junctions and establish barrier function. Canonical transcriptional signalling via Notch is highly conserved in metazoans and is required for many processes in vascular development, including arterial–venous differentiation3, angiogenesis4 and remodelling5. We establish the existence of a non-canonical cortical NOTCH1 signalling pathway that regulates vascular barrier function, and thus provide a mechanism by which a single receptor might link transcriptional programs with adhesive and cytoskeletal remodelling.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    & Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86, 279–367 (2006)

  2. 2.

    & Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol. Rev. 91, 327–387 (2011)

  3. 3.

    et al. Notch signaling is required for arterial–venous differentiation during embryonic vascular development. Development 19, 3675–3683 (2001)

  4. 4.

    et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776–780 (2007)

  5. 5.

    et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14, 1343–1352 (2000)

  6. 6.

    , & Molecular basis of the effects of shear stress on vascular endothelial cells. J. Biomech. 38, 1949–1971 (2005)

  7. 7.

    & Mechanotransduction in vascular physiology and atherogenesis. Nat. Rev. Mol. Cell Biol. 10, 53–62 (2009)

  8. 8.

    & Ischaemic brain oedema. J. Clin. Neurosci. 9, 113–124 (2002)

  9. 9.

    , , & Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function. Cardiovasc. Res. 87, 331–339 (2010)

  10. 10.

    , , , & Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc. Natl Acad. Sci. USA 98, 4478–4485 (2001)

  11. 11.

    , , & Cilia control vascular mural cell recruitment in vertebrates. Cell Reports 18, 1033–1047 (2017)

  12. 12.

    , & Notch signaling: cell fate control and signal integration in development. Science 284, 770–776 (1999)

  13. 13.

    Notch signalling in context. Nat. Rev. Mol. Cell Biol. 17, 722–735 (2016)

  14. 14.

    et al. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of Notch signaling. Mol. Cell. Biol. 23, 655–664 (2003)

  15. 15.

    , , , & Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am. J. Physiol. Heart. Circ. Physiol. 285, H1720–H1729 (2003)

  16. 16.

    et al. Mechanical allostery: evidence for a force requirement in the proteolytic activation of Notch. Dev. Cell 33, 729–736 (2015)

  17. 17.

    et al. Angiopoietin-1 requires p190 RHOGAP to protect against vascular leakage in vivo. J. Biol. Chem. 282, 23910–23918 (2007)

  18. 18.

    et al. A ligand-induced extracellular cleavage regulates γ-secretase-like proteolytic activation of NOTCH1. Mol. Cell 5, 197–206 (2000)

  19. 19.

    et al. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 405, 966–970 (2000)

  20. 20.

    , & Role of GTPases in control of microvascular permeability. Cardiovasc. Res. 87, 243–253 (2010)

  21. 21.

    et al. A local VE-cadherin and TRIO-based signaling complex stabilizes endothelial junctions through RAC1. J. Cell Sci. 128, 3041–3054 (2015)

  22. 22.

    et al. The multidomain protein TRIO binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate RAC-specific and RHO-specific guanine nucleotide exchange factor domains. Proc. Natl Acad. Sci. USA 93, 5466–5471 (1996)

  23. 23.

    , & Molecular separation of two signaling pathways for the receptor, Notch. Dev. Biol. 313, 556–567 (2008)

  24. 24.

    , , & A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J. Cell Biol. 196, 801–810 (2012)

  25. 25.

    et al. Intramembrane binding of VE-cadherin to VEGFR2 and VEGFR3 assembles the endothelial mechanosensory complex. J. Cell Biol. 208, 975–986 (2015)

  26. 26.

    et al. Mutations in NOTCH1 cause Adams-Oliver syndrome. Am. J. Hum. Genet. 95, 275–284 (2014)

  27. 27.

    et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 79, 169–173 (2006)

  28. 28.

    et al. NOTCH3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383, 707–710 (1996)

  29. 29.

    et al. A phase I dose escalation and expansion study of the anticancer stem cell agent demcizumab (anti-DLL4) in patients with previously treated solid tumors. Clin. Cancer Res. 20, 6295–6303 (2014)

  30. 30.

    et al. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat. Cell Biol. 16, 309–321 (2014)

  31. 31.

    , & Quantitative laser scanning confocal microscopy on single capillaries: permeability measurement. Microcirculation 1, 251–265 (1994)

  32. 32.

    , & Genesis: cluster analysis of microarray data. Bioinformatics 18, 207–208 (2002)

Download references


This work was supported in part by grants from the National Institutes of Health (EB00262, EB08396, UH3EB017103 and HL115553) and the National Science Foundation Center for Engineering MechanoBiology (CMMI15-48571). W.J.P. acknowledges support from a Ruth L. Kirchstein National Research Service Award (F32 HL129733) and from the NIH through the Organ Design and Engineering Training program (T32 EB16652), and M.L.K. acknowledges support from the Hartwell Foundation and the NIH through the Translational Research in Regenerative Medicine Training program (T32 EB005583). We thank P. A. Murphy and R. Wang for discussions of preliminary data and M. Schwartz for materials and discussions.

Author information

Author notes

    • William J. Polacheck
    •  & Matthew L. Kutys

    These authors contributed equally to this work.


  1. The Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA

    • William J. Polacheck
    • , Matthew L. Kutys
    • , Jinling Yang
    • , Jeroen Eyckmans
    •  & Christopher S. Chen
  2. The Biological Design Center and Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA

    • William J. Polacheck
    • , Matthew L. Kutys
    • , Jinling Yang
    • , Jeroen Eyckmans
    •  & Christopher S. Chen
  3. Yale Cardiovascular Research Center, Departments of Internal Medicine, Genetics, and Biomedical Engineering, New Haven, Connecticut, USA

    • Yinyu Wu
    • , Hema Vasavada
    •  & Karen K. Hirschi


  1. Search for William J. Polacheck in:

  2. Search for Matthew L. Kutys in:

  3. Search for Jinling Yang in:

  4. Search for Jeroen Eyckmans in:

  5. Search for Yinyu Wu in:

  6. Search for Hema Vasavada in:

  7. Search for Karen K. Hirschi in:

  8. Search for Christopher S. Chen in:


W.J.P., M.L.K., and C.S.C. conceived the study and designed experiments. W.J.P. and M.L.K. performed all experiments and data analysis with assistance from J.E. (qPCR) and J.Y. (Notch1-knockout mice). Y.W., H.V. and K.K.H. provided Notch1-knockout mice. W.J.P., M.L.K. and C.S.C. wrote the manuscript with input from all authors.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Christopher S. Chen.

Reviewer Information Nature thanks H. Gerhardt, I. Geudens, E. Tzima, A. Yap, and the other anonymous reviewer(s) for their contribution to the peer review of this work.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    This file contains Supplementary Tables 1-2 and the uncropped western blot scans with size marker indications.

  2. 2.

    Life Sciences Reporting Summary

About this article

Publication history







By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.